Invisible International

What Invisible International does

Invisible International operates in the medical education space through its VectorWise CME platform, a non-profit 501(c)(3) organization (Federal EIN: 84-4626505) that delivers free, accredited continuing medical education (CME) to clinicians on vector-borne diseases, with a primary thematic focus on Lyme disease and tick-borne illnesses. The platform is built on a web-based learning management system using third-party education platforms (Hotmart for course delivery and Teachable's CDN for content hosting), hosted at learn.vectorwisecme.org and accessible globally on a self-serve basis without sales intervention. Core offerings include a catalog of accredited CME courses — notably a two-part Lyme-Infection Associated Chronic Illness series (Part 1 at 0.5 CME credits on mechanisms/symptoms and Part 2 at 1.0 CME credit on treatment approaches) — supplemented by an article library, Lyme Disease Reported Case Maps, and printable clinical resources.

The organization is headquartered in Cambridge, United States, with 11-50 employees, and operates under founder & CEO Laura Lott and communications director Kris Newby. Its business model is donation-based rather than transactional: all CME content is provided free of charge to clinicians, and operations are sustained by charitable contributions solicited through a public "Donate" page and a Community Partners Program. Marketing reach relies on organic social channels — LinkedIn, Facebook, and Instagram — plus an email newsletter and content marketing via the article library. A core strategic partnership with the National Lyme and Tick-borne Disease Clinical Trials Network provides access to clinical trial data and research used in course content, anchoring the platform's clinical credibility.

Customer-facing distribution is exclusively through the self-serve online learning platform targeting individual clinicians and healthcare providers, with no enterprise B2B revenue model. The organization's value proposition centers on filling a documented gap in clinician training on vector-borne diseases in the context of climate-driven disease pattern shifts, while its non-profit structure and free pricing constitute its primary differentiators versus commercial CME competitors.

Name

Invisible International

Legal name

VectorWise CME

Website

https://invisible.international

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Invisible International operates the VectorWise CME platform, a 501(c)(3) non-profit that delivers free, accredited continuing medical education to clinicians on vector-borne diseases, with a primary focus on Lyme and tick-borne illnesses, funded by charitable donations.

Ownership category

akta.pro rank

Product category

Continuing Medical Education

NAICS

Educational Support Services (61171), Educational Services (611)

SIC

Services-Educational Services (8200), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Online/Hybrid Lifelong Learning Platforms & Open Enrollment Programs (EDAAAEAL)

akta.pro secondary industries

Core LMS Platforms (Academic & Corporate) (EDAFAAAA), Tick-Borne & Vector-Borne Diseases (HLAKAGAL), Open Accessibility & Inclusive OER (UDL, alt formats) (EDAGAJAJ)

Keywords

• Continuing medical education
• Vector-borne disease training
• Accredited CME courses
• Lyme disease education
• Clinical medical resources

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Donation-based funding: As a non-profit 501(c)(3) organization (Federal EIN: 84-4626505), VectorWise CME relies on charitable donations to sustain operations and provide free educational content to clinicians.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Invisible International operates the VectorWise CME platform, a free, accredited continuing medical education (CME) program for clinicians focused on vector-borne diseases such as Lyme disease and tick-borne illnesses. The platform delivers structured online courses (e.g., a two-part series on Lyme-infection associated chronic illness) supplemented by educational resources including an article library, Lyme disease case maps, and printable materials, all funded through charitable donations.

Product overview

VectorWise CME is a non-profit 501(c)(3) organization operating as a single, unified educational platform focused on providing free, accredited continuing medical education (CME) for vector-borne diseases. The core offering consists of a learning management system with a course catalog featuring structured CME courses, including a two-part Lyme-infection associated chronic illness series (Part 1 covering mechanisms and symptoms, Part 2 covering treatment approaches). The platform supplements courses with additional educational resources including an article library, Lyme disease case maps, and printable resources. All courses are delivered through third-party education platforms (Hotmart and Teachable) and are free to clinicians. The organization is funded through donations and operates under Federal EIN 84-4626505.

Differentiator

Problem solved

Functional benefit

Products and services

• VectorWise CME Platform A free, virtual, accredited continuing medical education platform empowering clinicians through vector-borne disease expertise. Delivers online courses, resources, and educational materials for healthcare professionals.
• Part 1: Persistent Symptoms and Mechanisms Underlying Lyme-Infection Associated Chronic Illness A 0.5 CME accredited course discussing prominent symptoms of post-treatment Lyme disease syndrome (PTLDS) and the pathophysiologic mechanisms underlying them. First in a two-part series on Lyme-infection associated chronic illness.
• Part 2: Approaches to the Treatment of Lyme-Infection Associated Chronic Illness A 1.0 CME accredited course discussing prior clinical trials of post-treatment Lyme disease syndrome (PTLDS), small case series, open label studies, and the national Lyme and Tick-borne Disease Clinical Trials Network. Second in a two-part series on Lyme-infection associated chronic illness.
• VectorWise CME Course Catalog A comprehensive catalog of accredited continuing medical education courses focused on vector-borne diseases, accessible through the learning management system at learn.vectorwisecme.org.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Partnerships

One partnership is on record.

• National Lyme and Tick-borne Disease Clinical Trials NetworkcoreStrategic or Co-development PartnerReferenced as a key clinical network partner in course content development. The partnership provides access to clinical trial data and research for CME course development on Lyme-infection associated chronic illness. Courses discuss the national network's activities and clinical trials.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/invisibleintl
• LinkedInlinkedin.com/company/vectorwisecme/about/?viewAsMember=true
• Instagraminstagram.com/learn.vectorwisecme
• Xx.com/invisibleintl

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Invisible International